[Hub]/) : Traits : Blood White Count :

chr1:160,391,398-162,630,958

Best TWAS P=3.71e-20 · Best GWAS P=9.95e-18 conditioned to 5.7e-64

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 CommonMind Brain Pre-frontal Cortex FCRLB 0.24 0.08 bslmm 499 0.19 1.7e-22 -4.46 6.8 8.0e-12 -0.15 1.00 0.00 TRUE
2 GTEx Adipose Subcutaneous PPOX 0.15 0.02 enet 34 0.03 9.4e-04 -6.13 5.5 4.8e-08 0.01 0.38 0.02 FALSE
3 GTEx Adipose Subcutaneous NIT1 0.16 0.06 enet 36 0.07 1.7e-06 -6.38 6.2 4.7e-10 -0.11 0.91 0.02 FALSE
4 GTEx Adipose Subcutaneous B4GALT3 0.21 0.05 enet 23 0.11 1.6e-09 3.81 6.4 2.0e-10 0.01 0.90 0.01 FALSE
5 GTEx Adipose Subcutaneous NDUFS2 0.06 0.09 lasso 4 0.07 2.0e-06 -5.65 6.6 3.9e-11 -0.08 0.89 0.00 TRUE
6 GTEx Adipose Subcutaneous FCGR2C 0.25 0.16 lasso 5 0.14 4.1e-11 -5.69 5.5 3.6e-08 -0.39 1.00 0.00 FALSE
7 GTEx Artery Tibial FCGR2C 0.17 0.03 enet 30 0.06 2.5e-05 -5.65 5.3 1.5e-07 -0.46 0.79 0.03 FALSE
8 GTEx Brain Hippocampus FCRLB 0.26 0.06 lasso 4 0.06 1.3e-02 -5.41 6.2 5.4e-10 -0.12 0.07 0.20 FALSE
9 GTEx Breast Mammary Tissue HSPA7 0.17 0.08 lasso 4 0.12 7.7e-07 -5.69 5.7 1.5e-08 -0.38 0.91 0.00 FALSE
10 GTEx Breast Mammary Tissue FCGR2C 0.15 0.13 lasso 2 0.09 2.1e-05 -5.69 5.7 1.5e-08 -0.39 0.75 0.01 FALSE
11 GTEx Cells Transformed fibroblasts B4GALT3 0.31 0.28 enet 16 0.30 2.0e-22 3.81 5.8 4.9e-09 -0.08 1.00 0.00 FALSE
12 GTEx Cells Transformed fibroblasts NDUFS2 0.11 0.07 lasso 3 0.10 1.2e-07 -6.13 5.8 5.1e-09 -0.03 0.64 0.02 FALSE
13 GTEx Colon Transverse NIT1 0.17 0.10 enet 8 0.13 1.1e-06 -6.52 5.3 9.5e-08 -0.03 0.77 0.01 FALSE
14 GTEx Muscle Skeletal FCGR2C 0.12 0.05 lasso 4 0.04 5.2e-05 -5.69 5.2 2.2e-07 -0.38 0.40 0.04 FALSE
15 GTEx Nerve Tibial PPOX 0.25 0.07 enet 43 0.15 6.7e-11 -6.52 7.1 1.5e-12 0.15 0.94 0.00 TRUE
16 GTEx Testis ATF6 0.23 0.08 lasso 6 0.05 3.3e-03 5.87 -5.6 1.9e-08 0.12 0.21 0.05 TRUE
17 GTEx Thyroid PPOX 0.12 0.00 lasso 6 0.01 6.1e-02 -4.18 5.5 5.0e-08 0.00 0.04 0.04 TRUE
18 GTEx Whole Blood FCGR2B 0.26 0.10 enet 35 0.14 9.4e-13 -5.61 -6.3 2.4e-10 0.51 0.98 0.02 FALSE
19 METSIM Adipose B4GALT3 0.05 0.03 lasso 7 0.04 2.7e-06 -5.51 5.8 8.1e-09 -0.09 0.96 0.00 FALSE
20 METSIM Adipose FCER1G 0.15 0.11 enet 15 0.12 6.3e-17 4.14 5.4 6.8e-08 -0.06 1.00 0.00 FALSE
21 METSIM Adipose FCGR2C 0.16 0.08 enet 27 0.10 3.3e-15 2.83 5.6 2.7e-08 -0.60 0.02 0.98 FALSE
22 METSIM Adipose NDUFS2 0.10 0.01 blup 393 0.05 1.3e-07 -2.68 6.3 3.1e-10 -0.19 0.96 0.00 FALSE
23 NTR Blood FCGR2B 0.25 0.06 enet 88 0.18 7.9e-57 -8.57 -7.7 2.0e-14 0.60 0.00 1.00 FALSE
24 NTR Blood MPZ 0.03 0.00 blup 417 0.00 4.8e-02 2.46 -5.8 6.0e-09 0.13 0.13 0.05 FALSE
25 YFS Blood B4GALT3 0.04 0.02 lasso 5 0.02 7.3e-08 -5.51 6.5 7.5e-11 -0.12 0.05 0.95 FALSE
26 YFS Blood FCGR2B 0.54 0.21 enet 101 0.38 9.1e-133 -5.61 -7.2 7.8e-13 0.53 0.98 0.02 FALSE
27 The Cancer Genome Atlas Breast Invasive Carcinoma FCER1G 0.03 0.02 lasso 4 0.03 1.8e-06 -5.55 6.2 7.1e-10 -0.10 0.15 0.84 FALSE
28 The Cancer Genome Atlas Breast Invasive Carcinoma HSPA7 0.04 0.02 enet 3 0.03 2.5e-06 -8.57 9.1 6.3e-20 -0.88 0.00 1.00 FALSE
29 The Cancer Genome Atlas Colon Adenocarcinoma HSPA7 0.06 0.03 lasso 2 0.02 2.7e-02 -8.57 8.7 4.2e-18 -1.00 0.00 0.84 FALSE
30 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma DUSP12 0.05 0.03 lasso 4 0.03 5.4e-04 -6.22 5.6 1.7e-08 -0.25 0.02 0.70 FALSE
31 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma HSPA7 0.03 0.02 lasso 1 0.01 8.7e-03 -8.57 8.6 1.0e-17 -1.00 0.00 0.84 FALSE
32 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma FCER1G 0.04 0.00 enet 11 0.02 4.2e-03 -6.52 6.6 5.3e-11 0.00 0.01 0.90 FALSE
33 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma FCGR2C 0.04 0.03 lasso 1 0.03 2.1e-04 -8.57 -8.6 1.0e-17 1.00 0.00 0.99 FALSE
34 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma HSPA7 0.02 0.02 lasso 1 0.01 1.2e-02 -8.57 8.6 1.0e-17 -1.00 0.00 0.87 FALSE
35 The Cancer Genome Atlas Brain Lower Grade Glioma DEDD 0.02 0.03 lasso 1 0.03 4.2e-04 -6.52 6.5 7.2e-11 -0.05 0.01 0.96 FALSE
36 The Cancer Genome Atlas Brain Lower Grade Glioma FCER1G 0.06 0.02 blup 71 0.05 2.7e-06 -5.65 6.2 6.3e-10 -0.09 0.08 0.82 FALSE
37 The Cancer Genome Atlas Brain Lower Grade Glioma FCRLB 0.09 0.00 blup 93 0.03 2.0e-04 -4.80 7.2 5.5e-13 -0.22 0.13 0.06 FALSE
38 The Cancer Genome Atlas Brain Lower Grade Glioma NR1I3 0.03 0.04 lasso 2 0.02 9.1e-04 -5.15 5.2 2.6e-07 0.01 0.40 0.05 FALSE
39 The Cancer Genome Atlas Lung Adenocarcinoma HSPA7 0.08 0.02 enet 3 0.05 9.2e-07 -0.72 7.3 2.6e-13 -0.53 0.00 0.53 FALSE
40 The Cancer Genome Atlas Lung Squamous Cell Carcinoma FCER1G 0.04 0.01 blup 72 0.01 7.7e-03 3.76 5.7 1.2e-08 -0.09 0.07 0.07 FALSE
41 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma HSPA7 0.05 0.00 enet 3 0.02 2.7e-02 -8.57 8.3 1.4e-16 -0.72 0.00 0.57 FALSE
42 The Cancer Genome Atlas Pancreatic Adenocarcinoma HSPA7 0.23 0.13 enet 3 0.14 1.5e-06 -8.57 9.2 3.7e-20 -0.95 0.00 1.00 TRUE
43 The Cancer Genome Atlas Pheochromocytoma and Paraganglioma TOMM40L 0.16 0.07 lasso 3 0.05 6.0e-03 -6.13 -6.2 7.2e-10 -0.03 0.01 0.82 FALSE
44 The Cancer Genome Atlas Prostate Adenocarcinoma FCER1G 0.10 0.07 blup 70 0.06 8.7e-07 -6.52 6.3 3.2e-10 0.01 0.00 1.00 FALSE
45 The Cancer Genome Atlas Prostate Adenocarcinoma HSPA7 0.06 0.01 enet 3 0.04 1.1e-04 -8.57 7.9 3.1e-15 -0.61 0.00 0.50 FALSE
46 The Cancer Genome Atlas Soft Tissue Sarcoma FCER1G 0.15 0.08 blup 70 0.09 3.3e-06 -2.68 5.4 5.8e-08 -0.05 0.02 0.97 FALSE
47 The Cancer Genome Atlas Testicular Germ Cell Tumors FCGR3B 0.36 0.00 enet 5 0.12 4.0e-05 -8.57 -7.4 1.2e-13 0.58 0.00 0.58 FALSE